针对膜心脏病的基于细胞外囊的工程治疗方法
Ana I Salazar-Puerta1, Mia Kordowski2, Tatiana Z Cuellar-Gaviria1
1Department of Biomedical Engineering, The Ohio State University, Fontana Laboratories, 140 W. 19th Ave., Columbus, OH 43210 USA.
Cellular and molecular bioengineering
|October 9, 2023
概括
工程化细胞外囊泡 (EVs) 将重编程因子传递给化的大动脉,成功诱导抗炎性巨细胞. 这种新的纳米载体方法为心脏膜疾病提供了有前途的治疗方法.
科学领域:
- 心血管研究研究心血管研究
- 纳米医学是一种纳米医学.
- 再生医学是一种再生医学.
背景情况:
- 膜性心脏病,特别是状大动脉狭窄症 (CAS),是老年人群的主要健康问题.
- 目前的治疗方法,如门置换,在长期耐用性方面存在局限性.
- 需要新的策略来阻止或逆转CAS进展.
研究的目的:
- 探索细胞外囊泡 (EV) 作为纳米载体的潜力,为患病的大动脉提供治疗有效载荷.
- 研究使用装有特定转录因子的工程EVs来减少炎症并促进化组织的再吸收.
主要方法:
- 设计的电动汽车装载了重编程髓质转录因子,CEBPA和Spi1.
- 这些EVs的传递遗传物质和诱导细胞转分的能力在患者衍生的大动脉组织中进行了评估.
- 在体外和体外模型被用来评估从内皮细胞诱导巨类细胞.
主要成果:
- 装有CEBPA和Spi1的工程电动汽车成功地从人类皮肤纤维细胞中衍生出来.
- 这些EV有效地传染了大动脉膜细胞,诱导了内皮细胞的转基因分化为抗炎性巨细胞.
- 在体外和体外都观察到成功的转差.
结论:
- 工程电动汽车显示出作为下一代纳米载体的潜力,用于准心脏门中的异常化.
- 这种方法可能为不适合进行门置换手术的高风险患者提供一种新的治疗选择.
更多相关视频
相关概念视频
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Valves
4.8K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
4.8K
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10


